Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

  • There is currently no data for DEMG

Director/PDMR Shareholding

25 May 2006 16:00

Deltex Medical Group PLC25 May 2006 25 May 2006 Deltex Medical Group plc Directors' Shareholdings Deltex Medical Group plc (the "Company"), the AIM quoted haemodynamic monitoringcompany, announces that it has today issued a total of 149,347 new ordinaryshares in the Company to certain non-executive directors and certain advisors tothe Company at a price of 20.00 pence per share. The five non-executive directors named below have elected to take shares in lieuof a cash payment as remuneration for their services to the Company. Inaddition certain of the Company's advisors have elected to take shares in lieuof cash payment for their services to the Company. Accordingly, application has been made for these shares to be admitted totrading on AIM. The shares rank pari passu with the existing issued shares ofthe Company and dealings are expected to commence on 01 June 2006. Followingthe issue of these new shares the Company has a total of 76,698,563 ordinaryshares in issue. Following this issue, the directors' beneficial interests are as follows: Name of Director Number of new Holding of shares following % of enlarged issued ordinary shares issue of new ordinary shares share capital issued in lieu of fees Nigel Keen (1) 31,250 4,187,546 5.46%Dr Edwin Snape (2) 22,500 3,207,750 4.18%Peter Smedvig (3) 22,500 1,142,115 1.49%Andy Hill - 172,486 0.22%Ewan Phillips - 767,156 1.00%George Flouty 26,257 295,335 0.39%Sir Duncan Nichol 17,550 71,015 0.09% Total 120,057 9,843,403 12.83% (1) Includes 589,700 shares held as trustee and executor of Pauline ThomasCharity Will Trust. (2) Includes shares held as a director of New England Partners andassociated companies. (3) Includes shares held as director of Peder Smedvig Capital AS. For further information, please contact:- Deltex Medical Group plc 01243 774 837Nigel Keen, Chairman nigel.keen@deltexmedical.comAndy Hill, Chief Executive andy.hill@deltexmedical.comEwan Phillips, Finance Director ewan.phillips@deltexmedical.com Charles Stanley 0207 953 2000Philip Davies Financial DynamicsDavid Yates/John Gilbert 0207 831 3113 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Sep 20167:00 amRNSThree new US platform programme accounts
8th Sep 20167:00 amRNSInterim results
15th Aug 201611:10 amRNSHolding(s) in Company
15th Jul 20164:00 pmRNSHolding(s) in Company
11th Jul 20167:00 amRNSResults from head to head trial presented
8th Jul 20167:00 amRNSPre-close Trading Update
1st Jul 20168:19 amRNSShare Subscription
17th Jun 20164:10 pmRNSDirector/PDMR Shareholding
9th Jun 20167:00 amRNSTwo new accounts added to US platform programme
1st Jun 20167:00 amRNSODM adopted into clinical guidelines in Spain
12th May 20161:10 pmRNSResult of AGM
12th May 20169:30 amRNSDirector/PDMR Shareholding
12th May 20167:01 amRNSTwo US accounts added to platform programme
12th May 20167:00 amRNSAGM Statement
4th May 20167:00 amRNSEnhanced performance TruFlow probe launched in UK
20th Apr 20163:25 pmRNSPosting of Annual Report and Notice of AGM
5th Apr 20167:00 amRNSTwo new US platform programme accounts opened
10th Mar 20167:00 amRNSPlacing and Issue of Shares
2nd Mar 20161:01 pmRNSHolding(s) in Company
25th Feb 201611:00 amRNSResult of General Meeting
23rd Feb 20167:00 amRNSResult of the Open Offer
8th Feb 20167:00 amRNSPosting of Circular
3rd Feb 20167:00 amRNSPlacing and issue of new convertible loan notes
27th Jan 20167:00 amRNSNew US platform programme account opened
27th Jan 20167:00 amRNSTrading Update
9th Dec 20157:00 amRNSTwo new US platform programme accounts opened
23rd Nov 20157:00 amRNSTwo new US platform programme accounts opened
20th Nov 20157:00 amRNSUS fluid variation study published by Premier
18th Nov 20157:00 amRNSOpen access e-learning courses launched
12th Nov 20157:00 amRNSNew US Platform Programme Account Opened
16th Sep 20157:00 amRNSInterim Results
9th Sep 20157:00 amRNSNew US platform programme account opened
21st Aug 201510:40 amRNSHolding(s) in Company
29th Jul 20157:00 amRNSFDA approves paediatric probes for launch in USA
28th Jul 20151:40 pmRNSAdditional Listing
14th Jul 20157:00 amRNSPre-close Trading Update
14th Jul 20157:00 amRNSCanadian tender won
1st Jul 20154:45 pmRNSDirector/PDMR Shareholding
30th Jun 20157:00 amRNSNew US platform programme account opened
24th Jun 20157:00 amRNSNew UK Government R&D funding secured
23rd Jun 20158:00 amRNSAdditional Listing
23rd Jun 20157:00 amRNSDeltex appoints new Group Finance Director
15th Jun 20157:00 amRNSGrant of options
12th Jun 20151:58 pmRNSHolding(s) in Company
9th Jun 20157:00 amRNSLeading US hospital improves surgical outcomes
2nd Jun 20157:00 amRNSBoard Changes
22nd May 201510:25 amRNSDirector Shareholding
12th May 20151:01 pmRNSResult of AGM
6th May 20158:00 amRNSDirectors' Shareholdings/Issue of equity
6th May 20157:02 amRNSFirst US 'remote training' account

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.